Because the eye is an immunologically privileged site [89, 90] and because retina cells do not seem to express MHC class I molecules [91], immunization against RAGE-1 could be considered against renal cell carcinoma, which express no cancer-germline genes. This evidence concerns the gene MOK and hereditary clear cell renal cell carcinoma.